Can I take Valeriana Officinalis with Ropinirole?
Oral Valeriana officinalis root and rhizome products; mixtures and other species are not assumed equivalent.
Read the interaction guide →Find the available answers about ropinirole and supplements. Each guide explains its evidence and the forms it covers.
19 published guides. Coverage is limited to the combinations listed.
Oral Valeriana officinalis root and rhizome products; mixtures and other species are not assumed equivalent.
Read the interaction guide →Oral 3,3′-diindolylmethane supplements, especially the absorption-enhanced formulation studied in small trials; I3C and ordinary vegetable intake are separate exposures.
Read the interaction guide →Withania somnifera products; the root-only trial does not establish equivalent effects for leaf extracts or mixed products.
Read the interaction guide →Oral Piper methysticum products; extraction method and composition vary.
Read the interaction guide →Oral indole-3-carbinol supplements studied at 400-800 mg daily; DIM supplements and ordinary cruciferous vegetables are different exposures.
Read the interaction guide →Purified oral prescription cannabidiol provides most of the evidence; nonprescription CBD formulations and other routes are not assumed equivalent.
Read the interaction guide →Specified oral Humulus lupulus hop-strobile preparations; combination sleep products, beer and isolated hop constituents are separate exposures.
Read the interaction guide →Paullinia cupana seed preparations containing caffeine; the actual amount depends on the product.
Read the interaction guide →Echinacea purpurea root and a separately studied E. purpurea extract; other species, plant parts and combination products are not equivalent.
Read the interaction guide →Caffeine intake during oral ropinirole treatment; advice about restless legs syndrome does not automatically apply to Parkinson disease.
Read the interaction guide →German chamomile flowering-top extract, with Matricaria recutita and Matricaria chamomilla identity supported by NCCIH; not Roman chamomile or an assumed tea-equivalent dose.
Read the interaction guide →Passiflora incarnata herb preparations, not fruit, another species or an assumed equivalent mixed product.
Read the interaction guide →Oral melatonin; licensed prolonged-release instructions and trial doses are preparation-specific.
Read the interaction guide →Oral Mucuna seed powders and extracts considered with immediate-release oral ropinirole. Evidence about prescription levodopa, selected seed preparations and commercial products is kept distinct; Parkinson-disease trials do not establish a treatment for restless legs syndrome.
Read the interaction guide →Pausinystalia johimbe products used alongside immediate-release oral ropinirole. Studies of measured pharmaceutical yohimbine are indirect for a whole-bark product or an extract with an unknown alkaloid amount.
Read the interaction guide →HPUS-labelled Rauwolfia serpentina preparations. One oral 6X-and-higher liquid is an identification example, not a match to every potency or product.
Read the interaction guide →Characterized oral THC/CBD cannabis extracts. Hempseed foods, cannabinoid-free preparations, isolated CBD and smoke exposure are distinct.
Read the interaction guide →Generic synephrine with immediate-release oral ropinirole. Human studies cited here used specified p-synephrine/bitter-orange products; they do not authenticate every product labeled synephrine or establish the effects of different stimulants.
Read the interaction guide →Oral L-arginine supplements. High-dose intravenous findings are not treated as equivalent to oral use.
Read the interaction guide →A supplement missing from this list has not been cleared for use with the medication. These pages do not assess every product, formulation, or combination.
Publication status, clinical review and change history are shown in each interaction guide.